Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 2
1984 2
1985 1
1986 5
1987 2
1988 11
1989 4
1990 2
1991 2
1992 1
1993 1
1994 2
1997 1
1999 5
2000 7
2001 7
2002 6
2003 5
2004 6
2005 4
2006 3
2007 12
2008 3
2009 9
2010 7
2011 7
2012 10
2013 10
2014 19
2015 10
2016 12
2017 7
2018 8
2019 11
2020 11
2021 9
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

214 results
Results by year
Filters applied: . Clear all
Page 1
Patient-Reported Symptoms Over 48 Weeks Among Participants in Randomized, Double-Blind, Phase III Non-inferiority Trials of Adults with HIV on Co-formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide versus Co-formulated Abacavir, Dolutegravir, and Lamivudine.
Wohl D, Clarke A, Maggiolo F, Garner W, Laouri M, Martin H, Quirk E. Wohl D, et al. Among authors: maggiolo f. Patient. 2018 Oct;11(5):561-573. doi: 10.1007/s40271-018-0322-8. Patient. 2018. PMID: 29956087 Free PMC article. Clinical Trial.
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials.
Orkin C, DeJesus E, Sax PE, Arribas JR, Gupta SK, Martorell C, Stephens JL, Stellbrink HJ, Wohl D, Maggiolo F, Thompson MA, Podzamczer D, Hagins D, Flamm JA, Brinson C, Clarke A, Huang H, Acosta R, Brainard DM, Collins SE, Martin H; GS-US-380-1489; GS-US-380-1490 study investigators. Orkin C, et al. Among authors: maggiolo f. Lancet HIV. 2020 Jun;7(6):e389-e400. doi: 10.1016/S2352-3018(20)30099-0. Lancet HIV. 2020. PMID: 32504574 Clinical Trial.
Efavirenz.
Maggiolo F. Maggiolo F. Expert Opin Pharmacother. 2007 Jun;8(8):1137-45. doi: 10.1517/14656566.8.8.1137. Expert Opin Pharmacother. 2007. PMID: 17516877 Review.
State of the Art of Dual Therapy in 2015.
Nozza S, Svicher V, Saracino A, d'Ettorre G, De Luca A, Maggiolo F, Bonora S, di Biagio A, Rusconi S, Mussini C. Nozza S, et al. Among authors: maggiolo f. AIDS Rev. 2015 Jul-Sep;17(3):127-34. AIDS Rev. 2015. PMID: 26450801 Review.
Enhancing care for people living with HIV: current and future monitoring approaches.
Maggiolo F, Bandera A, Bonora S, Borderi M, Calcagno A, Cattelan A, Cingolani A, Gianotti N, Lichtner M, Lo Caputo S, Madeddu G, Maggi P, Marchetti GC, Maserati R, Nozza S, Rusconi S, Zazzi M, Di Biagio A. Maggiolo F, et al. Expert Rev Anti Infect Ther. 2021 Apr;19(4):443-456. doi: 10.1080/14787210.2021.1823217. Epub 2020 Oct 15. Expert Rev Anti Infect Ther. 2021. PMID: 33054479 Free article. Review.
Marked decrease in acquired resistance to antiretrovirals in latest years in Italy.
Lai A, Franzetti M, Bergna A, Saladini F, Bruzzone B, Di Giambenedetto S, Di Biagio A, Lo Caputo S, Santoro MM, Maggiolo F, Parisi SG, Rusconi S, Gianotti N, Balotta C. Lai A, et al. Among authors: maggiolo f. Clin Microbiol Infect. 2021 Jul;27(7):1038.e1-1038.e6. doi: 10.1016/j.cmi.2020.09.028. Epub 2020 Sep 23. Clin Microbiol Infect. 2021. PMID: 32979570 Free article.
Abacavir + dolutegravir + lamivudine for the treatment of HIV.
Comi L, Maggiolo F. Comi L, et al. Among authors: maggiolo f. Expert Opin Pharmacother. 2016 Oct;17(15):2097-106. doi: 10.1080/14656566.2016.1232387. Epub 2016 Sep 13. Expert Opin Pharmacother. 2016. PMID: 27616133 Review.
214 results